梅克西莱丁:抗失常机制,新兴的临床应用和死亡率
Farah Olleik1, Mohammed Hussein Kamareddine1, Jenna Spears1
1Lankenau Medical Center and Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.
梅克西莱丁是一种抗心律失常药物,通过阻断通道来治疗心律障碍. 本综述探讨了它对心室节律失常和长QT综合征等疾病的益处和风险.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 梅克西莱丁是一种Ib类抗心律不良药.
- 它的主要机制涉及抑制心肌组织中的快速和迟 Na + 电流.
研究的目的:
- 综合研究西的治疗益处和风险.
- 加强其在治疗心室节律失常,长QT综合征和其他心律障碍方面的作用.
- 突出目前对其抗心律失常效应和非标签使用的理解.
主要方法:
- 在过去的五十年中发表的基础和临床研究的审查.
- 分析麦克西莱丁的死亡率和前节律影响.
主要成果:
- 梅克西莱丁的抗心律失常作用主要是由于Na+通道的抑制.
- 该审查综合了各种心脏病的疗效和安全性的证据.
结论:
- 梅克西莱丁仍然是特定心律失常的重要治疗选择.
- 了解它的好处和风险对于最佳的患者管理至关重要.
更多相关视频
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
09:20Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
